Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Cerebral haemorrhage; This is a spontaneous report from a contactable consumer downloaded from the regulatory authority-WEB [Regulatory Authority number SE-MPA-2021-038656], Safety Report Unique Identifier SE-VISMA-1620984232169. This is the first of two reports for the same patient, and pertains to the 2nd dose administered. A 94-year-old female patient received the 2nd dose of bnt162b2 (COMIRNATY), via an unspecified route of administration, on 10Feb2021, as single dose, for COVID-19 immunisation. Medical history included ongoing hypertension (controlled with medication). Concomitant medications were not reported. Previously the patient received the 1st dose of Comirnaty on 22Jan2021 and experienced dizziness and sick; earlier vaccinations with influenza vaccine (unknown manufacturer) for immunisation. The patient experienced cerebral haemorrhage (death) in Mar2021 with fatal outcome in Mar2021. The patient died in Mar2021 due to cerebral haemorrhage and dizziness. It was not reported if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender''s Comments: Linked Report(s) : SE-PFIZER INC-2021632027 Same patient, different dose/events; Reported Cause(s) of Death: Cerebral haemorrhage; Dizziness
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166